Polymorphisms in immune mediators associate with risk of cervical cancer
about
MiR-142 inhibits the development of cervical cancer by targeting HMGB1A novel mechanism of rs763110 polymorphism contributing to cervical cancer risk by affecting the binding affinity of C/EBPβ and OCT1 complex to chromatin.Effects of potentially functional polymorphisms in suppressor of cytokine signaling 3 (SOCS3) on the risk of head and neck squamous cancer.Role of inflammasome genetics in susceptibility to HPV infection and cervical cancer development.Familial clustering of oropharyngeal squamous cell carcinoma in the Utah population.Characterization of JAK2 V617F (1849 G > T) Mutation in Cervical Cancer Related to Human Papillomavirus and Sexually Transmitted Infections.
P2860
Polymorphisms in immune mediators associate with risk of cervical cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Polymorphisms in immune mediators associate with risk of cervical cancer
@ast
Polymorphisms in immune mediators associate with risk of cervical cancer
@en
Polymorphisms in immune mediators associate with risk of cervical cancer
@nl
type
label
Polymorphisms in immune mediators associate with risk of cervical cancer
@ast
Polymorphisms in immune mediators associate with risk of cervical cancer
@en
Polymorphisms in immune mediators associate with risk of cervical cancer
@nl
prefLabel
Polymorphisms in immune mediators associate with risk of cervical cancer
@ast
Polymorphisms in immune mediators associate with risk of cervical cancer
@en
Polymorphisms in immune mediators associate with risk of cervical cancer
@nl
P2093
P2860
P1433
P1476
Polymorphisms in immune mediators associate with risk of cervical cancer
@en
P2093
Janet S Rader
Samantha Fye
Zhengyan Zhang
P2860
P356
10.1016/J.YGYNO.2014.07.106
P407
P577
2014-08-12T00:00:00Z